Industry Segment and Operations by Geographic Areas

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Industry Segment and Operations by Geographic Areas

5. Industry Segment and Operations by Geographic Areas

The Company has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products.

Revenues by customer location are summarized as follows:

	Three Months Ended March 31,
	2014		2013
United States of America	$	3,914,659	$	3,527,287
Europe		1,085,096		933,639
Other		202,440		67,296
	$	5,202,195	$	4,528,222

Revenues by product type:

	Three Months Ended March 31,
	2014		2013
Injection products	$	4,806,782	$	3,436,500
Transdermal gel products		395,413		1,091,722
	$	5,202,195	$	4,528,222

Significant customers comprising 10% or more of total revenue are as follows:

	Three Months Ended March 31,
	2014		2013
Teva	$	2,448,287	$	2,455,266
Ferring		1,085,096		933,639
LEO Pharma		857,143		—
Actavis		166,627		874,328